C1IC34

R$452.65

0.00%

wb_incandescent Backtest

Stock

Cigna Corporation

Official Company Name: Cigna Corporation

Stock Symbol: C1IC34

Stock Market: B3 - Bovespa

Currency: Brazilian real - BRL

business Cigna Corporation Company Profile

C1IC34 Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▲+40.73%

file_download

Daily closing prices, with moving averages and volumes - Brazilian real (BRL)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

Cigna Corporation is a managed healthcare and insurance company. With its Cigna Global Health Benefits subsidiary, it provides medical, dental, disability, life and accident insurance, and related products and services primarily through employers’ subscriptions. Cigna also offers a full-service health maintenance organization, with clinics in the region of Phoenix, Arizona, through its Cigna Medical Group subsidiary.

business Cigna Corporation Company Profile

C1IC34 Stock Data

Open R$452.65
High R$452.65
Low R$452.65
Close R$452.65
Volume 0
Previous Close R$452.65
1-Day Change 0.00
1-Year Change 131.01
Average Daily Volume 28
52-Week High R$452.65
52-Week Low R$303.00
warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.